{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T05:07:36Z","timestamp":1697432856743},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1097\/lgt.0b013e31826cd7c1","type":"journal-article","created":{"date-parts":[[2013,4,3]],"date-time":"2013-04-03T09:29:40Z","timestamp":1364981380000},"page":"308-314","source":"Crossref","is-referenced-by-count":5,"title":["Hybrid Capture II Testing for High-Risk Human Papillomavirus DNA in the Follow-up of Women Treated for High-Grade Cervical Intraepithelial Neoplasia"],"prefix":"10.1097","volume":"17","author":[{"given":"Jeffrey H.J.","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne M.","family":"Garland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sepehr N.","family":"Tabrizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elya E.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer A.","family":"Danielewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-12-20210126","first-page":"CD001318","article-title":"Surgery for cervical intraepithelial neoplasia.","volume":"6","author":"Martin-Hirsch","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"R2-12-20210126","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0140-6736(96)08295-5","article-title":"Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia.","volume":"349","author":"Soutter","year":"1997","journal-title":"Lancet"},{"key":"R3-12-20210126","first-page":"1025","article-title":"Follow up after LLETZ: could schedules be modified according to risk of recurrence","volume":"108","author":"Flannelly","year":"2001","journal-title":"BJOG"},{"key":"R6-12-20210126","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1054\/bjoc.2000.1689","article-title":"Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia.","volume":"84","author":"Nobbenhuis","year":"2001","journal-title":"Br J Cancer"},{"key":"R7-12-20210126","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0090-8258(03)00415-3","article-title":"HPV testing can reduce the number of follow-up visits in women treated for cervical intraepithelial neoplasia grade 3.","volume":"9","author":"Zielinski","year":"2003","journal-title":"Gynecol Oncol"},{"key":"R9-12-20210126","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/j.1471-0528.2008.01748.x","article-title":"HPV testing as an adjunct to cytology in the follow up of women treated for cervical intraepithelial neoplasia.","volume":"115","author":"Kitchener","year":"2008","journal-title":"BJOG"},{"key":"R10-12-20210126","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.ejso.2010.08.135","article-title":"Predictors of recurrence in high-grade cervical lesions and a plan of management.","volume":"36","author":"Leguevaque","year":"2010","journal-title":"Eur J Surg Oncol"},{"key":"R11-12-20210126","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/jmv.21515","article-title":"HPV genotype prevalence in women with abnormal Pap smears in Melbourne, Australia.","volume":"81","author":"Stevens","year":"2009","journal-title":"J Med Virol"},{"key":"R12-12-20210126","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/AOG.0b013e3182020704","article-title":"Clearance of human papillomavirus in women treated for cervical dysplasia.","volume":"117","author":"Moore","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R13-12-20210126","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ajog.2008.11.031","article-title":"Posttreatment human papillomavirus testing for recurrent cervical intraepithelial neoplasia: a systematic review.","volume":"200","author":"Chan","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"R14-12-20210126","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1158\/1055-9965.EPI-05-0845","article-title":"For the ASCUS-LSIL Triage Study (ALTS) Group. HPV testing following loop electrosurgical excision procedure (LEEP) identifies women at risk for post-treatment cervical intraepithelial neoplasia grade 2 or 3 disease.","volume":"15","author":"Kreimer","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R15-12-20210126","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1447-0756.2008.00989.x","article-title":"High-risk human papillomavirus testing for monitoring patients treated for high-grade cervical intraepithelial neoplasia.","volume":"35","author":"Jeong","year":"2009","journal-title":"J Obstet Gynaecol Res"},{"key":"R16-12-20210126","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1479-828X.2009.01132.x","article-title":"Testing for high risk human papilloma virus in the initial follow-up of women treated for high-grade squamous intraepithelial lesions.","volume":"50","author":"Smart","year":"2010","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R17-12-20210126","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1128\/JCM.02438-06","article-title":"Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY HPV tests in detecting high-risk HPV genotypes in women with previous abnormal Pap smears.","volume":"45","author":"Stevens","year":"2007","journal-title":"J Clin Microbiol"},{"key":"R18-12-20210126","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ygyno.2006.10.011","article-title":"HPV16 and increased risk of recurrence after treatment for CIN.","volume":"104","author":"Gok","year":"2007","journal-title":"Gynecol Oncol"},{"key":"R19-12-20210126","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/ijc.25745","article-title":"Type-specific HPV geno-typing improves detection of recurrent high-grade cervical neoplasia after conisation.","volume":"129","author":"Heymans","year":"2011","journal-title":"Int J Cancer"}],"container-title":["Journal of Lower Genital Tract Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/LGT.0b013e31826cd7c1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:00:09Z","timestamp":1620957609000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00128360-201307000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/lgt.0b013e31826cd7c1","relation":{},"ISSN":["1089-2591"],"issn-type":[{"value":"1089-2591","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}